Published in TB and Outbreaks Week, October 6th, 1997
U.S. licensing of rotavirus vaccines is anticipated in the near future.
To evaluate vaccine safety and disease burden in U.S. children, the CDC has established the Vaccine Safety Datalink (VSD), a cohort of some 500,000 children enrolled in four health maintenance organizations. Data from this study were used to estimate the impact of rotavirus disease.
"The findings of this large cohort study indicate that rotavirus is a major cause of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.